{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:18:27Z","timestamp":1777349907890,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40618-019-01173-9","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T10:03:12Z","timestamp":1578045792000},"page":"853-858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Alternate-day calcium dosing may be an effective treatment option for chronic hypoparathyroidism"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-0004","authenticated-orcid":false,"given":"T.","family":"Akkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dagdeviren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. O.","family":"Koca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. T.","family":"Ertugrul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Altay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"1173_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1590\/2359-3997000000221","volume":"60","author":"MP Lopes","year":"2016","unstructured":"Lopes MP, Kliemann BS, Bini IB, Kulchetscki R, Borsani V, Savi L, Borba VZC, Moreira CA (2016) Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications. Arch Endocrinol Metab 60:532\u2013536. https:\/\/doi.org\/10.1590\/2359-3997000000221","journal-title":"Arch Endocrinol Metab"},{"key":"1173_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, Van Biesen W, Dekkers OM (2015) European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173:G1\u2013G20. https:\/\/doi.org\/10.1530\/EJE-15-0628","journal-title":"Eur J Endocrinol"},{"key":"1173_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000491046","volume":"51","author":"G Marcucci","year":"2019","unstructured":"Marcucci G, Brandi ML (2019) Conventional treatment of hypoparathyroidism. Front Horm Res 51:160\u2013164. https:\/\/doi.org\/10.1159\/000491046","journal-title":"Front Horm Res"},{"key":"1173_CR4","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1210\/jc.2015-3910","volume":"101","author":"MR Rubin","year":"2016","unstructured":"Rubin MR, Cusano NE, Bilezikian JP, Brandi ML, Potts JT Jr, Mannstadt M, Rejnmark L, Rizzoli R, Winer KK, Liberman UA (2016) Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab 101:2313\u20132324. https:\/\/doi.org\/10.1210\/jc.2015-3910","journal-title":"J Clin Endocrinol Metab"},{"key":"1173_CR5","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1210\/jc.83.10.3480","volume":"83","author":"KK Winer","year":"1998","unstructured":"Winer KK, Yanovski JA, Sarani B, Cutler GB (1998) A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1\u201334 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83:3480\u20133486. https:\/\/doi.org\/10.1210\/jc.83.10.3480","journal-title":"J Clin Endocrinol Metab"},{"key":"1173_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","volume":"1","author":"M Mannstadt","year":"2013","unstructured":"Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, Lakatos P, Bajnok L, Garceau R, Mosekilde L, Lagast H, Shoback D, Bilezikian JP (2013) Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol 1:275\u2013283. https:\/\/doi.org\/10.1016\/S2213-8587(13)70106-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1173_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1152\/physrev.00003.2004","volume":"85","author":"JGJ Hoenderop","year":"2005","unstructured":"Hoenderop JGJ, Nilius B, Bindels RJM (2005) Calcium absorption across epithelia. Physiol Rev 85:373\u2013422. https:\/\/doi.org\/10.1152\/physrev.00003.2004","journal-title":"Physiol Rev"},{"key":"1173_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1054\/ceca.2001.0201","volume":"29","author":"B Nilius","year":"2001","unstructured":"Nilius B, Prenen J, Vennekens R, Hoenderop JGJ, Bindels RJM, Droogmans G (2001) Modulation of the epithelial calcium channel, ECaC, by intracellular Ca2+. Cell Calcium 29:417\u2013428. https:\/\/doi.org\/10.1054\/ceca.2001.0201","journal-title":"Cell Calcium"},{"key":"1173_CR9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02228","author":"S Saha","year":"2019","unstructured":"Saha S, Goswami R (2019) Auditing the efficacy and safety of alfacalcidol and calcium therapy in idiopathic hypoparathyroidism. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2018-02228","journal-title":"J Clin Endocrinol Metab"},{"key":"1173_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13955","author":"A Al-Sharefi","year":"2019","unstructured":"Al-Sharefi A, Glenister E, Morris M, Quinton R (2019) Is calcium supplementation always needed in patients with hypoparathyroidism? Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.13955","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1173_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1359\/jbmr.061110","volume":"22","author":"SD Bianco","year":"2006","unstructured":"Bianco SD, Peng J-B, Takanaga H, Suzuki Y, Crescenzi A, Kos CH, Zhuang L, Freeman MR, Gouveia CH, Wu J, Luo H, Mauro T, Brown EM, Hediger MA (2006) Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res 22:274\u2013285. https:\/\/doi.org\/10.1359\/jbmr.061110","journal-title":"J Bone Miner Res"},{"key":"1173_CR12","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1210\/en.2007-1655","volume":"149","author":"BS Benn","year":"2008","unstructured":"Benn BS, Ajibade D, Porta A, Dhawan P, Hediger M, Peng J-B, Jiang Y, Oh GT, Jeung E-B, Lieben L, Bouillon R, Carmeliet G, Christakos S (2008) Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 149:3196\u20133205. https:\/\/doi.org\/10.1210\/en.2007-1655","journal-title":"Endocrinology"},{"key":"1173_CR13","first-page":"241","volume-title":"Calcium entry channels in non-excitable cells","author":"J-B Peng","year":"2018","unstructured":"Peng J-B, Suzuki Y, Gyimesi G, Hediger MA (2018) TRPV5 and TRPV6 calcium-selective channels. In: Kozak JA, Putney JW Jr (eds) Calcium entry channels in non-excitable cells. CRC Press\/Taylor & Francis, Boca Raton, pp 241\u2013274"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-019-01173-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-019-01173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:31:48Z","timestamp":1609547508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-019-01173-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1007\/s40618-019-01173-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"1 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by Kecioren Clinical Research Ethics Committee (2012-KAEK-15\/1811).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}